Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Graham Hughes/Photocall Ireland!
Jobswatch

95 jobs saved as pharmacy group emerges from examinership

Court protection will remain in place until 28 March.

MCSWEENEY PHARMACY GROUP has successfully emerged from examinership, securing 95 jobs at the firm.

The scheme of arrangement proposed by the examiner Declan McDonald has been approved at the High Court.

The plan will see the McSweeney Group, which employs 95 people across eight retail pharmacies, emerge from Examinership on 28 March.

Court protection will continue until noon of that date.

The interim examiner was appointed last October as the company had raked up about €17 million in debt.

The pharmacies affected Tohers The Chemists and Collooney Pharmacy in Sligo, Charlotte Quay Pharmacy in Limerick, Berminghams Pharmacy in Fermoy, Cassidys Pharmacy in Ennis, Dromahair Pharmacy in Leitrim, O’Hara’s Pharmacy and Medical and Clearys Pharmacy in Dublin. The McSweeney Group pharmacies in Northern Ireland were not affected.

The company said it now aims to further develop its healthcare services. It also hopes to expand the group with the addition of a number of medical centres in the near future.

Owner Geert Hof thanked McDonald and his company PwC, as well as KPMG and Arthur Cox. He also paid tribute to the staff and suppliers at McSweeney for their “continued support and tremendous efforts” during the process.

Your Voice
Readers Comments
3
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.